Through our webinars and e-learning videos, we aim to provide up-to-date information on the role of vitamin active pharmaceutical ingredients and pharmaceutical lipids. Together with guest speakers, our experts deliver relevant discussions on today’s prominent medical concerns and highlight key scientific findings from the latest clinical trials. 

Latest evidence and effects of vitamin D3-drug interactions

Fast-evolving science on the beneficial role of vitamin D3 (cholecalciferol) for immune health is gaining increasing interest among the medical communities. The strong therapeutic potential of vitamin D3 is supported by a vast body of research. However, several drugs can interfere with vitamin D3 metabolism. This webinar discusses the consequences of vitamin D3 drug interactions, as well as how the administration of vitamin D3 can ameliorate the pharmacologic action of some drugs.

From market trends to OTC innovation opportunities for immune health

Optimizing nutrient intake is one way to support a better immune response and build a more resilient immune system for a longer term. Intake in optimal amounts is necessary to support the complex immune system and help reduce the risk, duration and severity of a virus infection. Building on latest consumer insights, market trends, and scientific evidence presented by leading experts, this webinar discusses innovation opportunities meeting future consumer appeal on the OTC shelf.

In the current environment, consumers are increasingly exposed to a greater number of risks affecting their immune system. Growing consumer awareness is creating a ‘new normal’, driving demand for solutions to manage immune health holistically. Building on the scientific evidence presented by leading experts, this webinar discusses new solutions and innovation concepts driving consumer appeal in the pharma OTC market in EMEA.

Module: Understanding drug-nutrient interactions

Failure to identify and properly manage DNIs can lead to severe consequences on patient outcomes. Increased understanding of prevalence and clinical relevance of DNIs is critical. This e-learning module introduces how DNIs are defined and classified, highlights which populations are most at risk, and emphasizes how the negative effects of DNIs can be minimized. Experts present relevant case studies, based on latest scientific evidence.  

Emerging roles of lipids in the modulation of cancer risk and therapy - October 4, 2017

Presented by Prof. Catherine Field and Prof. Robert Chapkin, two of the world's leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy, the webinar will explore the current state of the science for EPA and DHA as a bioactive. Together with DSM's Dr. Keri Marshall, they will discuss the evidence for the use of lipids as a part of neoadjuvant therapy for two of the most common cancers: breast and colon. 

Latest Articles

APIs for Pharma Applications

Explore our broad portfolio of API Vitamins, Lipids and Novel APIs

Latest Scientific Research

Our whitepapers summarize the latest research developments, covering key topics in the industry

Quick Links


Request samples, place orders and view product documentation


Download the latest copy of our Solutions Catalogue

Contact Us

We’re more than a partner. We’re a competitive edge.


The latest in vitamin and lipid research and industry developments


Academic studies and the latest science in educational modules


Videos exploring the growing role of vitamin APIs and lipid API intermediates